Shareholders approve increase in authorized shares and equity plan amendment at 2023 annual meeting

MIMEDX GROUP, INC.

Shareholders approved raising authorized common shares from 187.5M to 250M (~81% in favor); amendment filed and effective June 14, 2023.
Approved amendment and restatement of 2016 Equity and Cash Incentive Plan (~77% in favor).
Re-elected directors Bierman, Gardner, Giuliani, Laurencin; say-on-pay passed ~89%; Deloitte ratified as auditor ~97%.
All five proposals at June 13, 2023 annual meeting were approved by requisite vote.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MIMEDX GROUP, INC.: Increased authorized common stock from 187,500,000 shares to 250,000,000 shares (effective 2023-06-14).

Change: charter amendment
Effective: 2023-06-14

Exact text from the filing

the Company filed the Articles of Amendment with the Secretary of State of the State of Florida, and the Articles of Amendment became effective on June 14, 2023.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.4

MIMEDX GROUP, INC. shareholders approved Approval of Articles of Amendment to increase authorized common stock from 187,500,000 to 250,000,000 at the 2023-06-13 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

(4) approved the Articles of Amendment to increase the number of shares of authorized common stock from 187,500,000 to 250,000,000

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.4

MIMEDX GROUP, INC. shareholders approved Advisory resolution regarding executive compensation at the 2023-06-13 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

(2) approved an advisory resolution regarding executive compensation

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.4

MIMEDX GROUP, INC. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm at the 2023-06-13 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

(3) ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.4

MIMEDX GROUP, INC. shareholders approved Election of Directors at the 2023-06-13 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

the shareholders: (1) re-elected James L. Bierman, Dr. Phyllis L. Gardner, Dr. Michael Giuliani, and Dr. Cato Laurencin

View on SEC.gov

Browse all governance changes →

MIMEDX GROUP, INC. filing history →

Source: SEC EDGAR

accession 0001376339-23-000033

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.